Report Detail
(Post-pandemic Era)-Global The Celecoxib Market Segment Research Report 2021
- RnM3485537 |
- 01 November, 2021 |
- Global |
- 88 Pages |
- XYZResearch |
- Medical Devices & Consumables
Summary
The global economy is expected to expand 5.6% in 2021，global recovery is strong but uneven as many emerging market and developing economies continue to struggle with the COVID-19 pandemic, the world is unlikely to ever reach global herd immunity. However, the recovery in many countries is being held back by a resurgence of COVID-19 cases and lagging vaccination progress, as well as the withdrawal of policy support in some instances.
The annual U.S. economic growth rate slipped to -3.5% in 2020, but grew at a yearly pace of more than 6% in the previous two quarters of 2021. The economy of continental Europe bounced back in the second quarter after having contracted in both the fourth quarter of 2020 and the first quarter of 2021, as the vaccinations accelerated, and governments eased restrictions. Among major economies, the annualized growth rate was 6.1% in Germany, 3.6% in France, 11.2% in Italy, and 11.7% in Spain. The especially rapid growth in Spain and Italy was attributed to a surge in consumer spending, likely the result of an easing of economic restrictions.
Regional Economic Prospects: Growth in the East Asia and Pacific is projected to accelerate by 7.7% in 2021, Central Asia is forecast to grow by 3.9% this year, economic activity in the Middle East and North Africa is forecast to advance by 2.4%, South Asia is projected to expand by 6.8%.
The global The Celecoxib market size was USD XX billion in 2021. It is likely to progress at a CAGR of XX% during the forecast period of 2022-2027, according to XYZResearch analysis, The segment in The Celecoxib market is estimated to reach a market value of USD XX billion by 2021 from an initial market value of USD XX billion in 2021. China market value in 2021 is about USD XX billion, and China The Celecoxib production is XX (K Units). US market value in 2021 is about USD XX billion, and US The Celecoxib production is XX (K Units). Europe market value in 2021 is about USD XX billion, and Europe The Celecoxib production is XX (K Units).
Regional Segmentation (Value; Revenue, USD Million, 2017 - 2027) of The Celecoxib Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in The Celecoxib Market?
Pfizer Inc
Apotex
Teva
Mylan
Hengrui Medicine
Lupin
...
Major Type of The Celecoxib Covered in XYZResearch report:
50mg
100mg
200mg
400mg
Application Segments Covered in XYZResearch Market
Rheumatoid arthritis
osteoarthritis
Acute pain
Musculoskeletal pain
Other diseases
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global The Celecoxib Market Segment Research Report 2021
1. Research Scope
2. Market Overview
- 2.1 Product Introduction, Application, Picture
- 2.2 Global The Celecoxib Market by Value
- 2.2.1 Global The Celecoxib Revenue by Type
- 2.2.2 Global The Celecoxib Market by Value (%)
- 2.3 Global The Celecoxib Market by Production
- 2.3.1 Global The Celecoxib Production by Type
- 2.3.2 Global The Celecoxib Market by Production (%)
3. The Major Driver of The Celecoxib Industry
- 3.1 Historical & Forecast Global The Celecoxib Demand
- 3.2 Largest Application for The Celecoxib (2017-2027)
- 3.3 The Major Downstream Company in China Market 2021
4. Global and Regional The Celecoxib Market
- 4.1 Regional Market Size in Terms of Production & Demand (2021)
- 4.2 Regional Market Share in Terms of Revenue (2019-2027)
- 4.3 Concentration Ratio (CR5& CR10) of The Celecoxib Market
- 4.4 Mergers & Acquisitions, Expansion Plans
5. US The Celecoxib Production, Demand (2017-2027)
- 5.1 Current and Estimated Production Breakdown by Type
- 5.2 Current and Estimated Demand Breakdown by Type
- 5.3 Current and Estimated Demand Breakdown by Application
- 5.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 5.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
6. Europe The Celecoxib Production, Demand (2017-2027)
- 6.1 Current and Estimated Production Breakdown by Type
- 6.2 Current and Estimated Demand Breakdown by Type
- 6.3 Current and Estimated Demand Breakdown by Application
- 6.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 6.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
7. China The Celecoxib Production, Demand (2017-2027)
- 7.1 Current and Estimated Production Breakdown by Type
- 7.2 Current and Estimated Demand Breakdown by Type
- 7.3 Current and Estimated Demand Breakdown by Application
- 7.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 7.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
8. Japan The Celecoxib Production, Demand (2017-2027)
- 8.1 Current and Estimated Production Breakdown by Type
- 8.2 Current and Estimated Demand Breakdown by Type
- 8.3 Current and Estimated Demand Breakdown by Application
- 8.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 8.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
9. India The Celecoxib Production, Demand (2017-2027)
- 9.1 Current and Estimated Production Breakdown by Type
- 9.2 Current and Estimated Demand Breakdown by Type
- 9.3 Current and Estimated Demand Breakdown by Application
- 9.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 9.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
10. Korea The Celecoxib Production, Demand (2017-2027)
- 10.1 Current and Estimated Production Breakdown by Type
- 10.2 Current and Estimated Demand Breakdown by Type
- 10.3 Current and Estimated Demand Breakdown by Application
- 10.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 10.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
11. Southeast Asia The Celecoxib Production, Demand (2017-2027)
- 11.1 Current and Estimated Production Breakdown by Type
- 11.2 Current and Estimated Demand Breakdown by Type
- 11.3 Current and Estimated Demand Breakdown by Application
- 11.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 11.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
12. Global The Celecoxib Average Price Trend
- 12.1 Market Price for Each Type of The Celecoxib in US (2017-2021)
- 12.2 Market Price for Each Type of The Celecoxib in Europe (2017-2021)
- 12.3 Market Price for Each Type of The Celecoxib in China (2017-2021)
- 12.4 Market Price for Each Type of The Celecoxib in Japan (2017-2021)
- 12.5 Market Price for Each Type of The Celecoxib in India (2017-2021)
- 12.6 Market Price for Each Type of The Celecoxib in Korea (2017-2021)
- 12.7 Market Price for Each Type of The Celecoxib in Southeast Asia (2017-2021)
13. Industrial Chain (Impact of COVID-19)
- 13.1 The Celecoxib Industrial Chain Analysis
- 13.2 Downstream
- 13.3 Impact of COVID-19
- 13.4 Technology Trends of The Celecoxib
14. The Celecoxib Competitive Landscape
- 14.1 Pfizer Inc
- 14.1.1 Pfizer Inc Company Profiles
- 14.1.2 Pfizer Inc Product Introduction
- 14.1.3 Pfizer Inc The Celecoxib Sales, Revenue (2017-2021)
- 14.1.4 Strategic initiatives
- 14.2 Apotex
- 14.2.1 Apotex Company Profiles
- 14.2.2 Apotex Product Introduction
- 14.2.3 Apotex The Celecoxib Sales, Revenue (2017-2021)
- 14.2.4 Strategic initiatives
- 14.3 Teva
- 14.3.1 Teva Company Profiles
- 14.3.2 Teva Product Introduction
- 14.3.3 Teva The Celecoxib Sales, Revenue (2017-2021)
- 14.3.4 Strategic initiatives
- 14.4 Mylan
- 14.4.1 Mylan Company Profiles
- 14.4.2 Mylan Product Introduction
- 14.4.3 Mylan The Celecoxib Sales, Revenue (2017-2021)
- 14.4.4 Strategic initiatives
- 14.5 Hengrui Medicine
- 14.5.1 Hengrui Medicine Company Profiles
- 14.5.2 Hengrui Medicine Product Introduction
- 14.5.3 Hengrui Medicine The Celecoxib Sales, Revenue (2017-2021)
- 14.5.4 Strategic initiatives
- 14.6 Lupin
- 14.6.1 Lupin Company Profiles
- 14.6.2 Lupin Product Introduction
- 14.6.3 Lupin The Celecoxib Sales, Revenue (2017-2021)
- 14.6.4 Strategic initiatives
15. Conclusion
Summary:
Get latest Market Research Reports on Celecoxib. Industry analysis & Market Report on Celecoxib is a syndicated market report, published as (Post-pandemic Era)-Global The Celecoxib Market Segment Research Report 2021. It is complete Research Study and Industry Analysis of Celecoxib market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
